Sandhya Mandlekar

4.9k total citations
70 papers, 3.6k citations indexed

About

Sandhya Mandlekar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Sandhya Mandlekar has authored 70 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 24 papers in Oncology and 13 papers in Immunology. Recurrent topics in Sandhya Mandlekar's work include Drug Transport and Resistance Mechanisms (14 papers), Genomics, phytochemicals, and oxidative stress (12 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Sandhya Mandlekar is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Genomics, phytochemicals, and oxidative stress (12 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Sandhya Mandlekar collaborates with scholars based in United States, India and Germany. Sandhya Mandlekar's co-authors include Rong Yu, Angela Kong, Rong Yu, Ah‐Ng Tony Kong, Tse‐Hua Tan, Chi Chen, Vidya Hebbar, Lei Wei, Rong Yu and Edward D. Owuor and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Sandhya Mandlekar

68 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandhya Mandlekar United States	28	2.1k	846	445	432	339	70	3.6k
Grace Chao Yeh United States	31	1.6k 0.8×	672 0.8×	238 0.5×	524 1.2×	239 0.7×	58	3.2k
Guy G. Chabot France	32	1.6k 0.8×	712 0.8×	481 1.1×	400 0.9×	292 0.9×	67	3.1k
Angelo Benedetti Italy	43	2.5k 1.2×	264 0.3×	485 1.1×	512 1.2×	626 1.8×	138	5.3k
Margaret M. Manson United Kingdom	46	3.7k 1.8×	811 1.0×	609 1.4×	503 1.2×	553 1.6×	109	6.3k
Ríona Mulcahy United States	39	3.9k 1.9×	535 0.6×	459 1.0×	159 0.4×	401 1.2×	115	5.8k
Sharad S. Singhal United States	48	5.3k 2.6×	1.8k 2.1×	387 0.9×	453 1.0×	393 1.2×	197	7.6k
Huidi Jiang China	32	1.3k 0.6×	661 0.8×	192 0.4×	536 1.2×	378 1.1×	145	3.2k
Xiaokui Huo China	40	2.4k 1.1×	1.0k 1.2×	391 0.9×	1.3k 2.9×	131 0.4×	225	5.3k
Dominique Delmas France	44	3.0k 1.4×	708 0.8×	286 0.6×	208 0.5×	906 2.7×	104	6.3k
Pawinee Piyachaturawat Thailand	30	1.2k 0.6×	536 0.6×	159 0.4×	595 1.4×	143 0.4×	138	3.0k

Countries citing papers authored by Sandhya Mandlekar

Since Specialization

Citations

This map shows the geographic impact of Sandhya Mandlekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandhya Mandlekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandhya Mandlekar more than expected).

Fields of papers citing papers by Sandhya Mandlekar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandhya Mandlekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandhya Mandlekar. The network helps show where Sandhya Mandlekar may publish in the future.

Co-authorship network of co-authors of Sandhya Mandlekar

This figure shows the co-authorship network connecting the top 25 collaborators of Sandhya Mandlekar. A scholar is included among the top collaborators of Sandhya Mandlekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandhya Mandlekar. Sandhya Mandlekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mandlekar, Sandhya, Dhruvitkumar S. Sutaria, Yixuan Zou, et al.. (2024). Evaluation of Patient‐Centric Sample Collection Technologies for Pharmacokinetic Assessment of Large and Small Molecules. Clinical Pharmacology & Therapeutics. 116(3). 782–794. 4 indexed citations

Huang, Weize, et al.. (2024). A Comparative Clinical Pharmacology Analysis of FDA‐Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology. Clinical Pharmacology & Therapeutics. 116(5). 1198–1206. 2 indexed citations

Subbaiah, Murugaiah A. M., Sarmistha Halder Sinha, Sandhya Mandlekar, et al.. (2022). Improving Drug Delivery While Tailoring Prodrug Activation to Modulate C_max and C_min by Optimization of (Carbonyl)oxyalkyl Linker-Based Prodrugs of Atazanavir. Journal of Medicinal Chemistry. 65(16). 11150–11176. 2 indexed citations

Subbaiah, Murugaiah A. M., Sarmistha Halder Sinha, Sandhya Mandlekar, et al.. (2020). (Carbonyl)oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentration. European Journal of Medicinal Chemistry. 207. 112749–112749. 5 indexed citations

Subbaiah, Murugaiah A. M., Sandhya Mandlekar, Sridhar Desikan, et al.. (2019). Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir. Journal of Medicinal Chemistry. 62(7). 3553–3574. 24 indexed citations

Subbaiah, Murugaiah A. M., Nicholas A. Meanwell, John F. Kadow, et al.. (2018). Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir. Journal of Medicinal Chemistry. 61(9). 4176–4188. 13 indexed citations

Chatterjee, Sagnik, et al.. (2017). Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay. Drug Metabolism and Disposition. 45(6). 604–611. 50 indexed citations

Kumar, Anoop, et al.. (2016). Single jugular vein cannulated rats may not be suitable for intravenous pharmacokinetic screening of high logP compounds. European Journal of Pharmaceutical Sciences. 99. 272–278. 4 indexed citations

Zhang, Yusheng, Young‐Hwan Han, Murali K. Matta, et al.. (2015). Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In Vitro. Drug Metabolism and Disposition. 44(3). 320–328. 60 indexed citations

10.

Sinha, Sarmistha Halder, et al.. (2014). Electrophilicity of Pyridazine-3-carbonitrile, Pyrimidine-2-carbonitrile, and Pyridine-carbonitrile Derivatives: A Chemical Model To Describe the Formation of Thiazoline Derivatives in Human Liver Microsomes. Chemical Research in Toxicology. 27(12). 2052–2061. 15 indexed citations

11.

Subramanian, Murali, Sheelendra Pratap Singh, Sonia Pahwa, et al.. (2013). Characterization of Recombinantly Expressed Rat and Monkey Intestinal Alkaline Phosphatases: In Vitro Studies and In Vivo Correlations. Drug Metabolism and Disposition. 41(7). 1425–1432. 6 indexed citations

12.

Bhutani, Priyadeep, Kaushik Ghosh, Manjunath Ramarao, et al.. (2013). Expression and Characterization of Cynomolgus Monkey Cytochrome CYP3A4 in a Novel Human Embryonic Kidney Cell–Based Mammalian System. Drug Metabolism and Disposition. 42(3). 369–376. 5 indexed citations

13.

Kole, Prashant, et al.. (2013). Conference Report: Applied Pharmaceutical Analysis India 2013 Conference Report. Bioanalysis. 5(15). 1821–1825.

14.

Zhao, Qihong, Jian Pang, Kim W. McIntyre, et al.. (2009). A CCR2/CCR5-dual antagonist, BMS-A, offers a potential novel oral therapy for the treatment of autoimmune disease (92.6). The Journal of Immunology. 182(Supplement_1). 92.6–92.6. 2 indexed citations

15.

Mandlekar, Sandhya, Jin‐Liern Hong, & Ah‐Ng Tony Kong. (2006). Modulation of Metabolic Enzymes by Dietary Phytochemicals: A Review of Mechanisms Underlying Beneficial Versus Unfavorable Effects. Current Drug Metabolism. 7(6). 661–675. 56 indexed citations

16.

Kong, Angela, Edward D. Owuor, Rong Yu, et al.. (2001). Induction of xenobiotic enzymes by the map kinase pathway and the antioxidant or electrophile response element (ARE/EpRE)^,†,^‡. Drug Metabolism Reviews. 33(3-4). 255–271. 270 indexed citations

17.

Kong, Ah‐Ng Tony, Rong Yu, Vidya Hebbar, et al.. (2001). Signal transduction events elicited by cancer prevention compounds. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 480-481. 231–241. 137 indexed citations

18.

Yu, Rong, Sandhya Mandlekar, Tse‐Hua Tan, & Angela Kong. (2000). Activation of p38 and c-Jun N-terminal Kinase Pathways and Induction of Apoptosis by Chelerythrine Do Not Require Inhibition of Protein Kinase C. Journal of Biological Chemistry. 275(13). 9612–9619. 99 indexed citations

19.

Yu, Rong, Lei Wei, Sandhya Mandlekar, et al.. (1999). Role of a Mitogen-activated Protein Kinase Pathway in the Induction of Phase II Detoxifying Enzymes by Chemicals. Journal of Biological Chemistry. 274(39). 27545–27552. 248 indexed citations

20.

Kong, Ah‐Ng Tony, Rong Yu, Lei Wei, et al.. (1998). Differential Activation of MAPK and ICE/Ced-3 Protease in Chemical-Induced Apoptosis. Restorative Neurology and Neuroscience. 12(2-3). 63–70. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact